A detailed history of California State Teachers Retirement System transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 191,325 shares of ALNY stock, worth $49.3 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
191,325
Previous 193,594 1.17%
Holding current value
$49.3 Million
Previous $47 Million 11.87%
% of portfolio
0.06%
Previous 0.06%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$233.81 - $287.01 $530,514 - $651,225
-2,269 Reduced 1.17%
191,325 $52.6 Million
Q2 2024

Aug 14, 2024

BUY
$143.31 - $247.0 $311,842 - $537,472
2,176 Added 1.14%
193,594 $47 Million
Q1 2024

May 15, 2024

SELL
$146.51 - $198.2 $23,441 - $31,712
-160 Reduced 0.08%
191,418 $28.6 Million
Q4 2023

Feb 13, 2024

BUY
$151.41 - $196.57 $203,949 - $264,779
1,347 Added 0.71%
191,578 $36.7 Million
Q3 2023

Nov 14, 2023

SELL
$170.77 - $211.65 $1.43 Million - $1.77 Million
-8,367 Reduced 4.21%
190,231 $33.7 Million
Q2 2023

Aug 21, 2023

SELL
$185.01 - $212.05 $862,886 - $989,001
-4,664 Reduced 2.29%
198,598 $37.7 Million
Q1 2023

May 09, 2023

BUY
$182.66 - $235.53 $279,652 - $360,596
1,531 Added 0.76%
203,262 $40.7 Million
Q4 2022

Feb 14, 2023

BUY
$185.53 - $241.31 $627,091 - $815,627
3,380 Added 1.7%
201,731 $47.9 Million
Q3 2022

Nov 18, 2022

SELL
$138.54 - $232.0 $224,434 - $375,840
-1,620 Reduced 0.81%
198,351 $39.7 Million
Q2 2022

Aug 15, 2022

BUY
$120.42 - $169.29 $91,278 - $128,321
758 Added 0.38%
199,971 $29.2 Million
Q1 2022

May 16, 2022

SELL
$127.18 - $173.91 $1.34 Million - $1.83 Million
-10,519 Reduced 5.02%
199,213 $32.5 Million
Q4 2021

Feb 15, 2022

BUY
$159.56 - $209.29 $692,490 - $908,318
4,340 Added 2.11%
209,732 $35.6 Million
Q3 2021

Nov 15, 2021

SELL
$169.75 - $207.73 $753,520 - $922,113
-4,439 Reduced 2.12%
205,392 $38.8 Million
Q2 2021

Aug 16, 2021

SELL
$128.63 - $176.89 $829,020 - $1.14 Million
-6,445 Reduced 2.98%
209,831 $35.6 Million
Q1 2021

May 18, 2021

BUY
$126.83 - $175.69 $129,366 - $179,203
1,020 Added 0.47%
216,276 $30.5 Million
Q4 2020

Feb 16, 2021

BUY
$122.97 - $147.0 $565,539 - $676,053
4,599 Added 2.18%
215,256 $28 Million
Q3 2020

Nov 17, 2020

BUY
$121.19 - $165.49 $822,758 - $1.12 Million
6,789 Added 3.33%
210,657 $30.7 Million
Q2 2020

Aug 17, 2020

BUY
$104.21 - $156.44 $1.74 Million - $2.61 Million
16,660 Added 8.9%
203,868 $30.2 Million
Q1 2020

May 13, 2020

BUY
$93.12 - $133.99 $60,993 - $87,763
655 Added 0.35%
187,208 $20.4 Million
Q4 2019

Feb 14, 2020

BUY
$74.51 - $124.23 $971,386 - $1.62 Million
13,037 Added 7.51%
186,553 $21.5 Million
Q3 2019

Nov 15, 2019

BUY
$70.9 - $87.82 $125,847 - $155,880
1,775 Added 1.03%
173,516 $14 Million
Q2 2019

Aug 14, 2019

BUY
$65.86 - $92.79 $1.26 Million - $1.78 Million
19,192 Added 12.58%
171,741 $12.5 Million
Q1 2019

May 09, 2019

BUY
$72.76 - $93.45 $597,577 - $767,504
8,213 Added 5.69%
152,549 $14.3 Million
Q4 2018

Feb 13, 2019

BUY
$62.67 - $88.33 $87,675 - $123,573
1,399 Added 0.98%
144,336 $10.5 Million
Q3 2018

Nov 14, 2018

BUY
$87.52 - $122.67 $1,225 - $1,717
14 Added 0.01%
142,937 $12.5 Million
Q2 2018

Aug 14, 2018

BUY
$88.31 - $107.8 $308,731 - $376,868
3,496 Added 2.51%
142,923 $14.1 Million
Q1 2018

May 15, 2018

SELL
$115.92 - $148.54 $330,603 - $423,636
-2,852 Reduced 2.0%
139,427 $16.6 Million
Q4 2017

Feb 14, 2018

BUY
$114.49 - $139.98 $1.44 Million - $1.76 Million
12,605 Added 9.72%
142,279 $18.1 Million
Q3 2017

Nov 13, 2017

BUY
$72.53 - $118.27 $9.41 Million - $15.3 Million
129,674
129,674 $15.2 Million

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $31.7B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.